Results 211 to 218 of about 114,575 (218)

Differential responses of PPARα, PPARδ, and PPARγ reporter cell lines to selective PPAR synthetic ligands

Analytical Biochemistry, 2005
Patrick Balaguer, Geraldine Lemaire, Arnaud Pillon   +2 more
exaly  

Impaired skin wound healing in peroxisome proliferator–activated receptor (PPAR)α and PPARβ mutant mice

Journal of Cell Biology, 2001
Béatrice Desvergne, Denis Duboule, Jennifer Rieusset   +2 more
exaly  

CRY1/2 Selectively Repress PPARδ and Limit Exercise Capacity

Cell Metabolism, 2017
Katja A Lamia, Weiwei Fan, Michael Downes   +2 more
exaly  

PPAR dual agonists: Are they opening Pandora's Box?

Pharmacological Research, 2007
Pitchai Balakumar, Pawan Krishan
exaly  

GW9662, a potent antagonist of PPARγ, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARγ agonist rosiglitazone, independently of PPARγ activation

British Journal of Pharmacology, 2004
Jason H. Gill
exaly  

The next generation of PPAR drugs: Do we have the tools to find them?

Biochimica Et Biophysica Acta - Molecular and Cell Biology of Lipids, 2007
Andrew N Billin, Barry G Shearer
exaly  

The role of PPARα in lipid metabolism and obesity: Focusing on the effects of estrogen on PPARα actions

Pharmacological Research, 2009
exaly  

PPARγΔ5, a Naturally Occurring Dominant-Negative Splice Isoform, Impairs PPARγ Function and Adipocyte Differentiation

Cell Reports, 2018
Simona Cataldi, Pietro Formisano, Marianna Aprile   +2 more
exaly